Abstract: The present invention relates to compounds with activity as BACE1 and NF?B modulators, and methods for treating, preventing, or ameliorating neurodegenerative diseases, such as Alzheimer's disease. The present invention is also directed to the treatment of diseases related to dysfunction of cell proliferation, the immune system and/or inflammation using such compounds or pharmaceutical compositions containing such candidate compounds.
Type:
Grant
Filed:
April 26, 2011
Date of Patent:
April 1, 2014
Assignee:
The Trustees of Columbia University in the city of New York
Inventors:
Donald W. Landry, Shi Xian Deng, Gangli Gong, Yuli Xie, Yidong Liu, K. Alison Rinderspacher
Abstract: A retractor device has an oximeter sensor at its tip, which allows measuring of oxygen saturation of a tissue being retracted by the retractor. The retractor device also has a force sensor which can measure an amount of force that is applied to the retracted tissue by the tip of the retractor device. The tip includes one or more openings for at least one source and detector. A specific implementation is a spinal nerve root retractor with an oximeter sensor and a force sensor.
Type:
Grant
Filed:
January 18, 2010
Date of Patent:
April 1, 2014
Assignees:
ViOptix, Inc., Regents of the University of California
Inventors:
Jimmy Jian-min Mao, Robert E. Lash, Shane Burch
Abstract: The instant invention describes macrocyclic compounds having therapeutic activity, and the mechanism and methods of treating disorders such as autoimmune diseases, inflammation, and cancer, tumors and cell proliferation related disorders.
Type:
Application
Filed:
May 17, 2012
Publication date:
March 27, 2014
Applicant:
University of Florida Research Foundation, Inc.
Abstract: Methods, compositions and kits for determining the developmental potential of one or more embryos or pluripotent cells and/or the presence of chromosomal abnormalities in one or more embryos or pluripotent cells are provided. These methods, compositions and kits find use in identifying embryos and oocytes in vitro that are most useful in treating infertility in humans.
Type:
Application
Filed:
February 23, 2012
Publication date:
March 27, 2014
Applicant:
The Board Of Trustees of the Leland Stanford Junior University
Inventors:
Shawn L. Chavez, Kevin E. Loewke, Barry Behr, Renee A. Reijo Pera
Abstract: A series of novel phosphorus-containing compounds having the following formula is provided: in which: R1-R4, A, Q and m are as defined in the specification. A process for the preparation of the compound of formula (I) is also provided. A polymer of formula (PA), and preparation process and use thereof are further provided. A polymer of formula (PI), and preparation process and use thereof are also provided.
Type:
Application
Filed:
October 31, 2013
Publication date:
March 27, 2014
Applicants:
National Chung Hsing University, Chang Chun Plastics Co., Ltd.
Inventors:
Ching-Hsuan LIN, Tsung Li Lin, Yu-Ting Fang, Kuen-Yuan Hwang, An-Pang Tu
Abstract: A synthesized siRNA molecule having the sense strand with one or more uridine bases replaced by one or more respective nucleoside analogs, such as 5-fluoro-2?-deoxyuridine (FdU).
Type:
Application
Filed:
September 18, 2013
Publication date:
March 27, 2014
Applicants:
University of Pittsburgh - Of the Commonwealth System of Higher Education, U.S. Department of Veterans Affairs
Inventors:
John C. SCHMITZ, SR., Edward Chu, William H. Gmeiner
Abstract: A game is executed in a normal round, in a first-type free round, and in a second-type free round. The normal round is executed with a first symbol set including a plurality of symbols. The first-type free round is executed with a second symbol set that includes at least one first symbol in addition to the symbols in the first symbol set. The second-type free round is executed with a third symbol set that includes at least one second symbol in addition to the symbols in the first symbol set, the at least one second symbol being different from the at least one first symbol.
Type:
Application
Filed:
September 21, 2012
Publication date:
March 27, 2014
Applicants:
Aruze Gaming America, Inc., Universal Entertainment Corporation
Abstract: An organic compound has the following chemical structure: wherein R is different from R*; R and R* are independently hydrogen, halogen, nitro or methoxyl; and R1 is a C1-C6 alkyl or a phenyl group. A quaternary data storage device includes a bottom electrode, a top electrode, and the organic film layer sandwiched between the bottom electrode and the top electrode.
Abstract: The present invention provides a method of predicting pregnancy outcome in a subject by determining the amount of an early pregnancy associated molecular isoform of hCG in a sample. The present invention further provides a method for determining the amount of early pregnancy associated molecular isoforms of human chorionic gonadotropin (hCG) in a sample. The present invention also provides a diagnostic kit for determining the amount of early pregnancy associated hCG in a sample. The present invention additionally provides an antibody which specifically binds to an early pregnancy associated molecular isoform of human chorionic gonadotropin. Finally, the present invention provides methods for detecting trophoblast or non-trophoblast malignancy in a sample.
Type:
Application
Filed:
March 18, 2013
Publication date:
March 27, 2014
Applicant:
The Trustees of Columbia University in the City of New York
Inventors:
John O'Connor, Steven Birken, Galina Kovalevskaya
Abstract: Molecules and compositions that can be used in the treatment of gynecologic cancers are described. ApoA-1, in particular, is demonstrated to inhibit the proliferation of cancer cells reduce tumor size in a mouse model of ovarian cancer.
Type:
Application
Filed:
October 4, 2011
Publication date:
March 27, 2014
Applicant:
The Regents of the University of California
Inventors:
Robin Farias-Eisner, Srinivasa T. Reddy
Abstract: A method of treating pre-term labor in pregnant human patient expressing melatonin receptors in her myometrial cells comprises administering an inhibitor of MT2R, an inhibitor of protein kinase C, an inhibitor of phospholipase C, or a combination thereof to the patient.
Type:
Application
Filed:
May 17, 2013
Publication date:
March 27, 2014
Applicant:
The Florida State University Research Foundation, Inc.
Abstract: An embodiment in accordance with the present invention provides a method for non-invasively determining the functional severity of coronary artery stenosis. The method includes gathering patient-specific data related to concentration of a contrast agent within a coronary artery of a patient using a coronary computed tomography angiography scan (CCTA). The patient-specific data is used to calculate a patient-specific transluminal attenuation gradient for the coronary artery of the patient. The patient specific transluminal attenuation gradient is used to determine an estimate of a coronary flow velocity, pressure gradient, loss coefficient, coronary flow reserve, and/or fractional flow reserve for the patient. Coronary flow velocity, pressure gradient, loss coefficient, coronary flow reserve, and fractional flow reserve can then be used to estimate the functional severity of coronary artery stenosis.
Type:
Application
Filed:
April 23, 2013
Publication date:
March 27, 2014
Applicant:
The Johns Hopkins University
Inventors:
Rajat Mittal, Albert C. Lardo, Jung Hee Seo
Abstract: A computer-implemented method includes, in one aspect, receiving a request for a spatial analysis of building behavior of an entity within a building facility; retrieving building maintenance information about the entity within the building facility; accessing a building information model for the building facility; identifying a portion of the building information model that pertains to the entity; and based on the retrieved building maintenance information and the identified portion of the building information model, generating the spatial analysis of the building behavior for the entity within the building facility.
Type:
Application
Filed:
September 26, 2013
Publication date:
March 27, 2014
Applicant:
Carnegie Mellon University
Inventors:
Asli Akcamete, Burcu Akinci, Xuesong Liu, James H. Garrett, JR.
Abstract: The present invention relates to the discovery that, in human cancer, an 11q deletion of ATM together with an increase in ATR and CHEK1 expression correlates with resistance to ionizing radiation which could be overcome by inhibition of the ATR/CHEK1 pathway. It provides for methods of identifying patients unlikely to exhibit an adequate response to radiation therapy and/or chemotherapy who may benefit from ATR/CHEK1 pathway inhibition, as well as methods of treating said patients.
Type:
Application
Filed:
April 23, 2013
Publication date:
March 27, 2014
Applicant:
University of Pittsburgh - of the CommonWealth System of Higher Education
Inventors:
Susanne M. Gollin, Rahul Atul Parikh, Xin Hijang
Abstract: Chelating monomers and fluoride-releasing compositions are disclosed that may be incorporated into dental composite restorative materials, dental bonding agents or other dental materials, to produce materials with high fluoride release rates, and high fluoride recharge capability. Such dental restorative materials may help reduce the level of dental caries in patients, particularly the level of caries occurring on the margins of the restorative materials.
Type:
Application
Filed:
November 12, 2013
Publication date:
March 27, 2014
Applicant:
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
Abstract: Perception of chitin fragments (chitooligosaccharides) is an important first step in plant defense response against fungal pathogen. LysM receptor-like kinases (LysM RLKs) are instrumental in this perception process. LysM RLKs also play a role in activating transcription of chitin-responsive genes (CRGs) in plants. Mutations in the LysM kinase receptor genes or the downstream CRGs may affect the fungal susceptibility of a plant. Mutations in LysM RLKs or transgenes carrying the same may be beneficial in imparting resistance against fungal pathogens.
Type:
Application
Filed:
October 7, 2013
Publication date:
March 27, 2014
Applicant:
The Curators of the University of Missouri
Inventors:
Jinrong Wan, Gary Stacey, Minviluz Stacey, Xuecheng Zhang
Abstract: A method for realizing adaptive quantization in image encoding and dequantization in image decoding is disclosed. In the adaptive quantization method, an image to be encoded is divided into one or more blocks, and each block is transformed to obtain one or more transform coefficients, the method comprising: acquiring parameter information of neighbor blocks of a current block; determining a quantization mode for the current block according to the parameter information of the neighbor blocks; and quantizing transform coefficients of the current block in the determined quantization mode. The quantization mode includes at least one of quantization matrix, quantization parameter and quantization step.
Abstract: Hollow conjugated polyelectrolyte (HCPE) microcapsules contain at least one conjugated polyelectrolyte and at least one other polyelectrolyte of complementary charge and the microcapsule has a hollow core. The conjugated polyelectrolyte is a polymer with a multiplicity of charged repeating units where a portion of the charged repeating units form a pi-conjugated sequence. The complementary polyelectrolyte is a polymer with a complementary charged repeating unit to the charged repeating units of the conjugated polyelectrolyte. The HCPE microcapsules can be formed by successively coating a sacrificial core with alternating layers of complementary polyelectrolytes, at least one of which is a conjugated polyelectrolyte. The sacrificial core can be removed to form the hollow center of a HCPE microcapsule.
Type:
Application
Filed:
November 27, 2013
Publication date:
March 27, 2014
Applicants:
STC.UNM, University of Florida Research Foundation, Inc.
Inventors:
Kirk S. Schanze, Motokatsu Ogawa, Jonathan Robert Sommer, David G. Whitten, Thomas S. Corbitt